Pliant Therapeutics, Inc. (NASDAQ:PLRX) Expected to Earn FY2023 Earnings of ($2.99) Per Share

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) – Investment analysts at Cantor Fitzgerald issued their FY2023 earnings per share estimates for shares of Pliant Therapeutics in a research report issued on Monday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos expects that the company will post earnings per share of ($2.99) for the year. Cantor Fitzgerald […]

Related Keywords

United States ,Canada ,Mike Ouimette ,Bernard Coulie ,Management Company Inc ,Canaccord Genuity Group ,Jpmorgan Chase Co ,Pliant Therapeutics Inc ,Nasdaq ,Quantamental Technologies ,Securities Exchange Commission ,Cantor Fitzgerald ,Blackstone Inc ,Needham Company ,Royal Bank ,Bessemer Group Inc ,Pliant Therapeutics ,Get Rating ,Pliant Therapeutic ,General Counsel Mike Ouimette ,Exchange Commission ,Pliant Therapeutics Daily ,Nasdaq Plrx ,Plrx ,Medical ,Earnings Estimates ,